Trial Profile
Special Drug-Use Results Survey of IMBRUVICA Capsules 140 mg (relapsed or refractory mantle cell lymphoma [MCL])
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2017
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Adverse reactions
- Sponsors Janssen Pharmaceutical KK
- 10 Jul 2017 New trial record